Veradermics Income Statement (2024-2026) | MANE

Income Statement Dec2024 Mar2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 0.74M0.74M0.75M22.70M41.78M
Operating items
Research & Development (Quarter) 11.45M20.93M18.61M
Selling, General & Administrative (Quarter) 1.47M8.94M10.95M
Operating Expenses (Quarter) 12.91M29.86M29.55M
Operating Income (Quarter) -12.91M-29.86M-29.55M
EBIT (Quarter) -12.91M-29.86M-29.55M
Non-operating items
Interest & Investment Income (Quarter) 0.48M2.48M4.84M
Other Non Operating Income (Quarter) 0.03M0.15M1.21M
Non Operating Income (Quarter) 0.52M2.63M6.05M
Net income details
EBT (Quarter) -12.40M-27.23M-23.50M
Profit After Tax (Quarter) -14.58M-0.58M-23.87M
Income from Non-Controlling Interests (Quarter) -0.58M-0.37M
Income from Continuing Operations (Quarter) -12.40M-27.23M-23.50M
Consolidated Net Income (Quarter) -12.40M-27.23M-23.50M
Income towards Parent Company (Quarter) -12.40M-27.23M-23.50M
Net Income towards Common Stockholders (Quarter) -14.58M-30.01M-23.50M
Additional items
EPS (Basic) (Quarter) -19.79-1.32-0.58
EPS (Diluted) (Quarter) -19.79-1.32-0.58
Shares Outstanding (Quarter) 0.74M0.74M0.74M22.70M40.44M
Shares Outstanding (Diluted) (Quarter) 0.74M0.74M0.74M22.70M40.44M
EBITDA (Quarter) -12.91M-29.86M-29.55M
Interest Expenses (Quarter) 15.40M0.07M0.79M